Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

US10556916B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10556916-B2
Application numberUS-201515300883-A
CountryUS
Kind codeB2
Filing dateApr 1, 2015
Priority dateApr 1, 2014
Publication dateFeb 11, 2020
Grant dateFeb 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a method of preparing a 89 Zr-oxine complex of the formula. The invention also provides a method of labeling a cell with the 89 Zr-oxine complex and a method for detecting a biological cell in a subject comprising administering the 89 Zr-oxine complex to the subject.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of labeling a cell or microorganism with 89 Zr-oxine complex comprising contacting the cell or microorganism with a 89 Zr-oxine complex of the formula in a buffer solution at 26° C. or below, wherein the 89 Zr-oxine complex permeabilizes the cell membrane of the cell or microorganism. 2. The method of claim 1 wherein the 89 Zr-oxine complex-labeled cells or microorganisms are washed free of non-internalized 89 Zr. 3. The method of claim 1 , wherein the cell is a healthy cell. 4. The method of claim 3 , wherein the healthy cell is a T cell, a natural killer (NK) cell, a dendritic cell, a macrophage, a monocyte, a B cell, a myeloid cell, a platelet, a stem cell, a progenitor cell, a mesenchymal cell, an epithelial cell, a neural cell, a skeletal myoblast, or a pancreatic islet cell. 5. The method of claim 1 , wherein the buffer solution further comprises a second labeling agent, whereby the cell or microorganism is labeled with both 89 Zr-oxine complex and the second labeling agent.

Assignees

Inventors

Classifications

  • using radioactive material · CPC title

  • in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors · CPC title

  • Electrochemically active labels · CPC title

  • involving radioactive labelled substances · CPC title

  • Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10556916B2 cover?
The invention provides a method of preparing a 89 Zr-oxine complex of the formula. The invention also provides a method of labeling a cell with the 89 Zr-oxine complex and a method for detecting a biological cell in a subject comprising administering the 89 Zr-oxine complex to the subject.
Who is the assignee on this patent?
Us Health
What technology area does this patent fall under?
Primary CPC classification C07F7/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).